Outcome Trajectories in Drug Court: Do All Participants Have Drug Problems?

Overview

Journal Crim Justice Behav

Publisher Sage Publications

Date 2011 Nov 15

PMID 22081732

Citations 8

Authors

David DeMatteo

Douglas B Marlowe

David S Festinger

Patricia L Arabia

Affiliations

Soon will be listed here.

Abstract

Graduation rates in drug courts average 50% to 70%, but it is unclear what proportion of graduates responded to the drug court services and what proportion might not have had serious drug problems upon entry. This study cluster-analyzed urine drug screen results during the first 14 weeks of treatment on 284 participants from three misdemeanor drug courts. A four-cluster solution (R(2) > .75) produced distinct subgroups characterized by (1) consistently drug-negative urine specimens (34% of the sample), (2) consistently drug-positive specimens (21%), (3) consistently missed urine specimens (26%), and (4) urine specimens that began as drug-positive but became progressively drug-negative over time (19%). These data suggest that approximately one-third of the participants might not have had serious drug problems upon entry. Approximately one-fifth appeared to respond to drug court services, and nearly one-half continued to exhibit problems after 14 weeks. Implications for adaptive programming in drug courts are discussed.

Citing Articles

Healthcare expenditures for people with substance use disorders in drug courts compared to their peers in traditional courts.

Montgomery B, Aldridge A, Drawbridge D, Packer I, Vincent G, Rodriguez-Monguio R Drug Alcohol Depend Rep. 2024; 12:100258.

PMID: 39156655 PMC: 11327541. DOI: 10.1016/j.dadr.2024.100258.

Adult Drug Treatment Courts and Community-Level Drug Possession Arrests.

Hibbard P Crime Delinq. 2024; 70(6-7):1567-1591.

PMID: 38855171 PMC: 11160559. DOI: 10.1177/00111287221131496.

Effectiveness of substance use disorder treatment as an alternative to imprisonment.

Virtanen S, Aaltonen M, Latvala A, Forsman M, Lichtenstein P, Chang Z BMC Psychiatry. 2024; 24(1):260.

PMID: 38589822 PMC: 11003076. DOI: 10.1186/s12888-024-05734-y.

United States drug courts and opioid agonist therapy: Missing the target of overdose reduction.

Csete J Forensic Sci Int Mind Law. 2021; 1:100024.

PMID: 34171038 PMC: 7280826. DOI: 10.1016/j.fsiml.2020.100024.

IDENTIFYING PREDICTORS OF SUBSTANCE USE AND RECIDIVISM OUTCOME TRAJECTORIES AMONG DRUG TREATMENT COURT CLIENTS.

Wilson J, Bandyopadhyay S, Yang H, Cerulli C, Morse D Crim Justice Behav. 2020; 45(4):447-467.

PMID: 33060870 PMC: 7556699. DOI: 10.1177/0093854817737806.

References

Marlowe D, Festinger D, Lee P, Dugosh K, Benasutti K . Matching Judicial Supervision to Clients' Risk Status in Drug Court. Crime Delinq. 2008; 52(1):52-76. PMC: 2174271. DOI: 10.1177/0011128705281746. View

McLellan A, Luborsky L, Woody G, OBrien C . An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis. 1980; 168(1):26-33. DOI: 10.1097/00005053-198001000-00006. View

Reid R, Pipe A, Higginson L, Johnson K, Slovinec DAngelo M, Cooke D . Stepped care approach to smoking cessation in patients hospitalized for coronary artery disease. J Cardiopulm Rehabil. 2003; 23(3):176-82. DOI: 10.1097/00008483-200305000-00003. View

Murphy S, Lynch K, Oslin D, McKay J, TenHave T . Developing adaptive treatment strategies in substance abuse research. Drug Alcohol Depend. 2006; 88 Suppl 2:S24-30. PMC: 1922034. DOI: 10.1016/j.drugalcdep.2006.09.008. View

Marlowe D, Festinger D, Dugosh K, Lee P, Benasutti K . Adapting judicial supervision to the risk level of drug offenders: discharge and 6-month outcomes from a prospective matching study. Drug Alcohol Depend. 2006; 88 Suppl 2:S4-13. PMC: 1885231. DOI: 10.1016/j.drugalcdep.2006.10.001. View

Marlowe D, Festinger D, Arabia P, Dugosh K, Benasutti K, Croft J . Adaptive Interventions in Drug Court: A Pilot Experiment. Crim Justice Rev. 2009; 33(3):343-360. PMC: 2735275. DOI: 10.1177/0734016808320325. View

Marlowe D, Merikle E, Kirby K, Festinger D, McLellan A . Multidimensional assessment of perceived treatment-entry pressures among substance abusers. Psychol Addict Behav. 2001; 15(2):97-108. DOI: 10.1037//0893-164x.15.2.97. View

Festinger D, Marlowe D, Lee P, Kirby K, Bovasso G, McLellan A . Status hearings in drug court: when more is less and less is more. Drug Alcohol Depend. 2002; 68(2):151-7. DOI: 10.1016/s0376-8716(02)00187-4. View

Marlowe D, Festinger D, Dugosh K, Lee P . Are judicial status hearings a "key component" of drug court? Six and twelve months outcomes. Drug Alcohol Depend. 2005; 79(2):145-55. DOI: 10.1016/j.drugalcdep.2005.01.019. View

10.

Peters R, Greenbaum P, Steinberg M, Carter C, Ortiz M, Fry B . Effectiveness of screening instruments in detecting substance use disorders among prisoners. J Subst Abuse Treat. 2000; 18(4):349-58. DOI: 10.1016/s0740-5472(99)00081-1. View

11.

Kidorf M, Neufeld K, King V, Clark M, Brooner R . A stepped care approach for reducing cannabis use in opioid-dependent outpatients. J Subst Abuse Treat. 2007; 32(4):341-7. DOI: 10.1016/j.jsat.2006.09.005. View

12.

Marlowe D, Festinger D, Foltz C, Lee P, Patapis N . Perceived deterrence and outcomes in drug court. Behav Sci Law. 2005; 23(2):183-98. DOI: 10.1002/bsl.636. View

13.

Morral A, Iguchi M, Belding M, Lamb R . Natural classes of treatment response. J Consult Clin Psychol. 1997; 65(4):673-85. DOI: 10.1037//0022-006x.65.4.673. View

14.

Wills T, Vaccaro D, McNamara G, Hirky A . Escalated substance use: a longitudinal grouping analysis from early to middle adolescence. J Abnorm Psychol. 1996; 105(2):166-80. DOI: 10.1037//0021-843x.105.2.166. View

15.

Prochaska J, Velicer W, Guadagnoli E, Rossi J, DiClemente C . Patterns of Change: Dynamic Typology Applied to Smoking Cessation. Multivariate Behav Res. 2016; 26(1):83-107. DOI: 10.1207/s15327906mbr2601_5. View

16.

Brooner R, Kidorf M, King V, Stoller K, Neufeld K, Kolodner K . Comparing adaptive stepped care and monetary-based voucher interventions for opioid dependence. Drug Alcohol Depend. 2007; 88 Suppl 2:S14-23. PMC: 1948819. DOI: 10.1016/j.drugalcdep.2006.12.006. View

17.

McLellan A, Kushner H, Metzger D, Peters R, Smith I, Grissom G . The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat. 1992; 9(3):199-213. DOI: 10.1016/0740-5472(92)90062-s. View

18.

Rikoon S, Cacciola J, Carise D, Alterman A, McLellan A . Predicting DSM-IV dependence diagnoses from Addiction Severity Index composite scores. J Subst Abuse Treat. 2006; 31(1):17-24. DOI: 10.1016/j.jsat.2006.03.003. View

19.

Breslin F, Sobell M, Sobell L, Cunningham J, Borsoi D . Problem drinkers: evaluation of a stepped-care approach. J Subst Abuse. 2000; 10(3):217-32. DOI: 10.1016/s0899-3289(99)00008-5. View

20.

Magura S, Kang S, Nwakeze P, Demsky S . Temporal patterns of heroin and cocaine use among methadone patients. Subst Use Misuse. 1998; 33(12):2441-67. DOI: 10.3109/10826089809059334. View